Science and technology

Chair, since 1980, and Managing Director, since 2001, East Lancashire Deaf Society; Chief Executive, Royal National Institute for Deaf People, 1995–97

MD; FRCP

R. D. Lawrence Professor of Diabetic Medicine, King’s College London, since 1995

Kt 1998; PhD, ScD; FRCPath, FMedSci; FRSE; FRSB

President, Royal Society of Edinburgh, 2011–14; Chairman, Greater Glasgow and Clyde (formerly Greater Glasgow) NHS Board, 2002–07

Kt 2009; PhD; FRCS, FRCOG

Professor and Head of Obstetrics and Gynaecology, St George’s, University of London (formerly St George’s Hospital Medical School), 2001–13, now Emeritus; President, British Medical Association, 2013–14

PhD

Chief Scientific Officer, Vertual Ltd, since 2007; Head, Medical Physics, Hull University Teaching Hospitals NHS Trust (formerly Head, Radiation Physics, Hull and East Yorkshire NHS Hospitals Trust), since 2008

PhD; FRCP; FAHA

British Heart Foundation Professor of Cardiovascular Sciences, University of Cambridge, since 2000; Hon. Consultant Cardiologist, Cambridge University Hospitals NHS Trust, since 2000

FRCSI; FMedSci

Professor of Laryngology, University College London, since 2009; Programme Director, UCL-Partners, since 2010

MD

Professor of Microbiology and Immunology, since 1972, and of Biochemistry and Biophysics, since 1982, University Professor, since 1994, Director, G. W. Hooper Research Foundation, since 1981, and Chancellor, 1998–2009, now Chancellor Emeritus, University of California, San Francisco

PhD, DSc; FRCPSGlas, FFPH, FRCPE, FRCPI, FMedSci; FRSE

President, International Prevention Research Institute, since 2009; Professor of Global Public Health, University of Strathclyde, and Director, University of Strathclyde Institute for Global Public Health at International Prevention Research Institute, since 2013; President, World Prevention Alliance, since 2011

PhD, MD; FIEEE

President, Salk Institute for Biological Studies, California, 2009–15, now Professor Emeritus

MBE 2011; FRCVS; FRSB

Chairman, Alphavet International Ltd, 2015–17

MD

Regental Professor, University of Texas; Paul J. Thomas Chair in Medicine, Jonsson Center for Molecular Genetics, since 1977, and W. A. Moncrief Distinguished Chair in Cholesterol and Arteriosclerosis Research, since 1989, University of Texas Southwestern Medical School at Dallas

OBE 2014; PhD; FRSE; FRSC, CBiol, FRSB

Professor of Molecular Microbiology, University of Edinburgh, 2008–12, now Emeritus; Director, Blackah-Brown Consulting, since 2013

CPhys; FInstP

Wheatstone Professor of Physics, King’s College, London, 1989–2000; Director, Leverhulme Trust Grant to Cavendish Laboratory, University of Cambridge, 1994–98

Kt 1985; DL; CEng, FIMechE, FIMarEST

Chairman, Trent Regional Health Authority, 1982–94

DSc

Founder Trustee and Chair, Mental Health Research UK, since 2008; published poet

PhD; FRCP, FRCPath, FMedSci

Professor of Neurology and Head, Department of Clinical Neurosciences, University of Cambridge, since 2015

OBE 2002; PhD, DM; FRCP, FFOM, FFPH, FMedSci

Professor of Occupational and Environmental Medicine, MRC Lifecourse Epidemiology Unit (formerly Environmental Epidemiology Unit, then Epidemiology Resource Centre), University of Southampton, 1997–2015, now Emeritus

PhD; CEng, FREng, FIET; FRSocMed; FRSE

Professor of Bioengineering, since 1999, and Director, Strathclyde Institute of Medical Devices, since 2006, University of Strathclyde; Chief Executive Officer, Ohmedics Ltd, since 2009

CBE 2008

Chief Executive Officer, Institute of Physics and Engineering in Medicine, 2012–19